United States

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

5:20am EST
Change (% chg)

Rs-0.45 (-0.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Cipla says unit entered definitive agreement to sell stake in Four M Propack
Wednesday, 18 Jan 2017 07:05am EST 

Cipla Ltd : Says unit entered in to a definitive agreement to sell its 100% equity stake in Four M Propack, India .Cipla ltd says deal for a consideration of INR 135 million.  Full Article

Cipla's flagship product Sereflo gets final nod from UK MHRA
Friday, 23 Dec 2016 04:28am EST 

Cipla Ltd : Cipla’s flagship product Sereflo receives final approval from UK MHRA . Cipla’s sereflo will be launched in the UK through a partner in the coming weeks .Product used for treatment of asthma.  Full Article

Cipla gets EIR from USFDA for its Indore facility
Wednesday, 12 Oct 2016 07:47am EDT 

Cipla Ltd :Cipla receives EIR from the US FDA for its Indore facility.  Full Article

Cipla Ltd exec says co expects about 200 mln rupees of impact from FDC ban, NLEM in Q2
Friday, 12 Aug 2016 08:51am EDT 

Cipla Ltd : Cipla's Samina Vaziralli says "the family is completely committed", "absolutely no prospect" of selling the company . Exec says expects about 200 million rupees of impact from FDC ban and NLEM in Q2 . Further company coverage [CIPL.NS] ((Bangalore.newsroom@thomsonreuters.com)).  Full Article

Cipla Ltd appoints Umang Vohra as MD, global CEO
Friday, 12 Aug 2016 06:11am EDT 

Cipla Ltd : Accepted resignation of Subhanu Saxena as MD and global CEO wef August 31 . Appointed Umang Vohra as MD and global CEO .  Full Article

Cipla Ltd June-qtr consol profit down about 44 pct
Friday, 12 Aug 2016 06:08am EDT 

Cipla Ltd : June-quarter consol net profit 3.65 billion rupees . June-quarter consol net sales 35 billion rupees . Consensus forecast for June-quarter net profit was 3.76 billion rupees . Consol net profit in June-quarter last year was 6.49 billion rupees as per Ind-AS; consol net sales was 37.61 billion rupees .  Full Article

Cipla appoints Kedar Upadhye as CFO
Monday, 1 Aug 2016 12:46am EDT 

Cipla Ltd : Kedar Upadhye has joined the company as Global Chief Financial Officer with effect from August 01, 2016 . Umang Vohra relinquishes office as Global Chief Financial Officer of the company with effect from August 01, 2016 .  Full Article

Cipla Ltd says co to deposit 1.75 bln rupees with 6 weeks as per court order in drug overcharging case
Friday, 22 Jul 2016 10:13am EDT 

Cipla Ltd : Supreme court has directed government to recover 50% of over charged amounts, in pending cases on alleged overcharging in respect of certain drugs . Co is required to deposit 1.75 billion rupees with 6 weeks .  Full Article

Cipla appoints Kedar Upadhye as global CFO
Wednesday, 8 Jun 2016 03:54am EDT 

Cipla Ltd : Approved the appointment of Kedar Upadhye as global chief financial officer of the company . Umang Vohra will cease to be the global chief financial officer of the company . Vohra will continue to be the global chief operating officer .  Full Article

Cipla says co expects EBITDA growth of 15-20 pct in fiscal 2017
Tuesday, 24 May 2016 09:33am EDT 

Cipla Ltd : Says plans to file for approval of 20 to 25 products in U.S. in fiscal 2017 . Says looking to exit some businesses in emerging markets "due to complexities involved" . Says Q4 impacted by inventory and job cuts related provisions in Europe, emerging markets . Says expects EBITDA growth of 15-20 percent in fiscal 2017 . Further company coverage [CIPL.NS] ((Bengaluru Newsroom; +91 80 6749 1130)).  Full Article

UPDATE 1-India's Cipla Q2 profit falls as Europe, emerging markets suffer

MUMBAI, Nov 9 Cipla Ltd, India's fifth-largest drugmaker by sales, on Wednesday reported a 35 percent fall in quarterly profit, missing analysts' estimates, mainly due to lower sales in the emerging markets and Europe.